|
|
Volumn 13, Issue 2, 2008, Pages 112-116
|
|
Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan
|
|
Author keywords
Chemoradiation; Locally advanced; Non small cell lung cancer
|
|
Indexed keywords
CISPLATIN;
DOCETAXEL;
ERLOTINIB;
GEFITINIB;
MITOMYCIN;
VINDESINE;
ADVANCED CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER LOCALIZATION;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER RESEARCH;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMPUTER ASSISTED RADIOTHERAPY;
CONFERENCE PAPER;
HUMAN;
INOPERABLE CANCER;
LUNG NON SMALL CELL CANCER;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RADIATION DEPTH DOSE;
RADIATION DOSE;
RADIATION DOSE FRACTIONATION;
SURVIVAL RATE;
SURVIVAL TIME;
THERAPY EFFECT;
THREE DIMENSIONAL IMAGING;
TREATMENT RESPONSE;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS AS TOPIC;
COMBINED MODALITY THERAPY;
HUMANS;
JAPAN;
LUNG NEOPLASMS;
PLATINUM COMPOUNDS;
RADIOTHERAPY DOSAGE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 43449127501
PISSN: 13419625
EISSN: None
Source Type: Journal
DOI: 10.1007/s10147-007-0754-y Document Type: Conference Paper |
|
Times cited : (20)
|
|
References (34)
|
